| Literature DB >> 34115636 |
Tobias P Gonzenbach1, Shay P McGuinness1,2,3, Rachael L Parke1,2,3,4, Tobias M Merz1.
Abstract
OBJECTIVES: Nonpharmaceutical interventions are implemented internationally to mitigate the spread of severe acute respiratory syndrome coronavirus 2 with the aim to reduce coronavirus disease 2019-related deaths and to protect the health system, particularly intensive care facilities from being overwhelmed. The aim of this study is to describe the impact of nonpharmaceutical interventions on ICU admissions of non-coronavirus disease 2019-related patients.Entities:
Mesh:
Year: 2021 PMID: 34115636 PMCID: PMC8439630 DOI: 10.1097/CCM.0000000000005166
Source DB: PubMed Journal: Crit Care Med ISSN: 0090-3493 Impact factor: 9.296
ICU Admissions and ICU Resource Utilization
| ICU Admissions and Resource Utilization | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|
|---|---|---|---|---|---|---|---|
| Total admissions per capita (million) | 456.3 | 505.8 | 441.9 | 439.3 | 432.6 | 277.0 | < 0.0001 |
| Acute admission (%) | 293.1 (64.2) | 314.1 (62.1) | 256.5 (67.1) | 292.3 (66.5) | 312.7 (72.3) | 191.5 (69.1) | < 0.0001 |
| Elective admission (%) | 163.2 (35.8) | 191.6 (37.9) | 145.4 (32.9) | 147.1 (33.5) | 119.9 (27.7) | 85.6 (30.9) | < 0.0001 |
| ICU occupancy (%) | 61.7 | 69.5 | 62.5 | 65.9 | 62.1 | 38.7 | 0.0006 |
| Length of stay, mean (95% CI), hr | 67 (61–72) | 64 (59–69) | 65 (60–70) | 68 (62–73) | 67 (62–71) | 64 (58–69) | 0.85 |
| Ventilation hours total (per patient) | 50,678 (58.9) | 27,443 (48.8) | |||||
| % of patients ventilated | 40.5 | 40.5 |
Patient Characteristics
| Patient Characteristics | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|
|---|---|---|---|---|---|---|---|
| Age, mean (95% CI), yr | 57 (57–58) | 57 (56–58) | 56 (55–57) | 57 (56–58) | 57 (56–58) | 58 (57–59) | 0.21 |
| ≤ 44, | 498 (23.9) | 546 (23.1) | 538 (25.6) | 524 (24.7) | 528 (24.8) | 328 (23.6) | 0.55 |
| 45–64, | 644 (30.8) | 787 (33.3) | 665 (31.6) | 684 (32.2) | 673 (31.7) | 465 (33.5) | 0.27 |
| 65–84, | 860 (41.2) | 945 (40) | 816 (38.8) | 856 (40.3) | 859 (40.4) | 558 (40.2) | 0.98 |
| ≥ 85, | 86 (4.1) | 84 (3.6) | 84 (4.0) | 60 (2.8) | 65 (3.1) | 38 (2.7) | 0.16 |
| Male sex % | 60 | 59 | 60 | 60 | 60 | 59 | 0.47 |
| Acute Physiologic Assessment and Chronic Health Evaluation III score, mean (95% CI) | 56 (55–58) | 54 (53–55) | 56 (55–57) | 56 (55–57) | 55 (53–56) | 55 (53–57) | 0.02 |
| ICU mortality, % | 8.1 | 5.9 | 7.3 | 7.6 | 7.5 | 6.0 | 0.68 |
| Hospital mortality, % | 11.3 | 8.6 | 9.9 | 10.6 | 10.5 | 8.0 | 0.96 |
| Diagnostic groups per capita million, | |||||||
| Cardiovascular | 145.9 (32.0) | 160.0 (31.6) | 143.7 (32.5) | 144.2 (32.8) | 134.4 (31.1) | 84.0 (30.3) | 0.63 |
| Respiratory | 62.5 (13.7) | 67.9 (13.4) | 59.7 (13.5) | 54.4 (12.4) | 60.5 (14.0) | 37.1 (13.4) | 1.00 |
| Gastrointestinal | 61.8 (13.5) | 69.2 (13.7) | 50.9 (11.5) | 55.0 (12.5) | 47.4 (11.0) | 33.9 (12.2) | 0.16 |
| Neurologic | 37.3 (8.2) | 45.6 (9.0) | 36.4 (8.2) | 42.4 (9.7) | 39.3 (9.1) | 25.5 (9.2) | 0.74 |
| Sepsis | 38.5 (8.3) | 38.5 (7.6) | 38.0 (8.6) | 35.0 (8.0) | 36.4 (8.4) | 29.1 (10.5) | 0.21 |
| Trauma | 31.5 (6.9) | 34.0 (6.7) | 30.7 (6.9) | 28.1 (6.4) | 36.2 (8.4) | 16.2 (5.8) | 0.53 |
| Metabolic | 23.8 (5.2) | 30.2 (6.0) | 23.3 (5.3) | 28.3 (6.5) | 39.9 (6.9) | 21.9 (7.9) | 0.19 |
| Hematologic | 1.1 (0.2) | 1.5 (0.3) | 1.3 (0.3) | 1.7 (0.4) | 1.0 (0.2) | 0.8 (0.3) | 0.60 |
| Renal/genitourinary | 12.7 (2.8) | 15.4 (3.0) | 14.9 (3.4) | 15.7 (3.6) | 15.7 (3.6) | 12.0 (4.3) | 0.38 |
| Musculoskeletal/skin | 19.2 (4.2) | 21.6 (4.3) | 17.7 (4.0) | 18.4 (4.2) | 17.5 (4.0) | 8.8 (3.2) | 0.63 |
| Gynecologic | 4.1 (0.9) | 5.4 (1.1) | 5.9 (1.3) | 5.4 (1.2) | 5.7 (1.3) | 4.2 (1.5) | 0.77 |
| No diagnosis | 18.3 (4.0) | 16.5 (3.3) | 19.5 (4.4) | 10.8 (2.4) | 8.6 (2.0) | 3.6 (1.3) | 0.14 |
| Diagnostic subgroups per capita million, | |||||||
| Heart failure/cardiogenic shock | 6.3 (1.4) | 7.7 (1.5) | 6.1 (1.4) | 5.6 (1.3) | 8.3 (1.9) | 3.8 (1.4) | 1.00 |
| Myocardial infarction/cardiac arrest | 15.3 (3.3) | 15.0 (3.0) | 20.0 (4.5) | 19.6 (4.5) | 19.1 (4.4) | 8.8 (3.2) | 0.74 |
| Respiratory infections | 10.5 (2.3) | 15.0 (3.0) | 14.1 (3.2) | 10.5 (2.4) | 18.9 (4.4) | 8.0 (2.9) | 1.00 |
| Stroke/intracranial hemorrhage | 16.2 (3.5) | 16.1 (3.2) | 16.6 (3.8) | 18.6 (4.2) | 20.2 (4.7) | 10.8 (3.9) | 0.36 |
| Gynecologic/obstetric | 4.4 (1.0) | 5.8 (1.1) | 6.9 (1.6) | 6.6 (1.5) | 6.3 (1.5) | 4.4 (1.6) | 0.79 |